Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial
Title:
Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial
Author:
Di Liello, Raimondo Arenare, Laura Raspagliesi, Francesco Scambia, Giovanni Pisano, Carmela Colombo, Nicoletta Frezzini, Simona Tognon, Germana Artioli, Grazia Gadducci, Angiolo Lauria, Rossella Ferrero, Annamaria Cinieri, Saverio De Censi, Andrea Breda, Enrico Scollo, Paolo De Giorgi, Ugo Lissoni, Andrea Alberto Katsaros, Dionyssios Lorusso, Domenica Salutari, Vanda Cecere, Sabrina Chiara Lapresa, Mariateresa Nardin, Margherita Bogani, Giorgio Distefano, Mariagrazia Greggi, Stefano Gargiulo, Piera Schettino, Clorinda Gallo, Ciro Daniele, Gennaro Califano, Daniela Perrone, Francesco Pignata, Sandro Piccirillo, Maria Carmela
Appeared in:
International journal of gynecological cancer
Paging:
Volume 31 () nr. 10 pages 1348-1355
Year:
2021
Contents:
Publisher:
IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.